Y70 (Rabeprazole Sodium Delayed-Release 20 mg)
Pill with imprint Y70 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Aurobindo Pharma Limited.
Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Y70

Rabeprazole Sodium Delayed-Release
- Imprint
- Y70
- Strength
- 20 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0721
- Inactive Ingredients
-
diacetylated monoglycerides,
ethylcellulose (7 mPa.s),
ferric oxide yellow,
hypromellose phthalate (31% phthalate, 40 cst),
magnesium stearate,
mannitol,
magnesium oxide,
magnesium hydroxide,
sodium carbonate,
magnesium silicate,
titanium dioxide,
ferrosoferric oxide,
shellac
Note: Inactive ingredients may vary.
Related images for "Y70"
More about rabeprazole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (78)
- Drug images
- Pricing & coupons
- En español
- Drug class: proton pump inhibitors
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.